The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Open accessAbstract
After 20 years follow‐up of newly diagnosed patients with Parkinson's disease (PD), 100 of 136 (74%) have died. The mortality rate fell in the first 3 years of treatment, then rose compared to the general population, the standardized mortality ratio from 15 to 20 years reaching 3.1. Drug induced dyskinesia and end of dose failure were experienced by most patients, but the main current problems relate to the non‐levodopa responsive features of the disease. Dementia is present in 83% of 20‐year survivors. Dementia correlates with increasing age and probably reflects an interplay of multiple pathologies. Seventeen people with dementia had postmortems. Eight had diffuse Lewy bodies as the only cause of dementia, while others had mixed neuropathology. Only one person lives independently and 48% are in nursing homes. Excessive daytime sleepiness is noted in 70%, falls have occurred in 87%, freezing in 81%, fractures in 35%, symptomatic postural hypotension in 48%, urinary incontinence in 71%, moderate dysarthria in 81%, choking in 48%, and hallucinations in 74%. The challenge is to understand the cellular mechanisms underlying the diverse features of advanced PD that go far beyond a lack of dopamine. © 2008 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Development and validation of a geriatric depression screening scale: a preliminary report
Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90033-4 · Cited by 15,025 · cited 1×
“Depression was assessed by the 30 item Geriatric Depression Scale (GDS).(23) Hallucinations were detected by routine questioning at each visit of the patient, and carer when present.”
MethodThe Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citationA New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
The FAB: A frontal assessment battery at bedside
Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000) · Neurology · doi:10.1212/wnl.55.11.1621 · Cited by 3,913
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
A systematic review of prevalence studies of dementia in Parkinson's disease
Aarsland, D., Zaccai, J., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,689
Parkinson, J. (2002) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.14.2.223 · Cited by 1,628
Prevalence and Characteristics of Dementia in Parkinson Disease: An 8-Year Prospective Study
Aarsland, D., Andersen, K., Larsen, J. P., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,401
Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years
Hely, M. A., Morris, J. G. L., Reid, W. G. J., & Trafficante, R. (2005) · Movement Disorders · doi:10.1002/mds.20324 · Cited by 1,050
Self-citation
Research works printed but not linked: 4
- Kaplan E, 1983, The Boston naming test
- StataCorp 2005 Stata Statistical Software: Release 9
- 10.1212/WNL.40.1.38 · DOI
- 10.1007/s00415-006-0234-8 · DOI · Paper page
Cited by
Items 101–121 of 121
Reduced occipital GABA in Parkinson disease with visual hallucinations
Firbank, M. J., Parikh, J., Murphy, N., Killen, A., Allan, C. L., Collerton, D., Blamire, A. M., & Taylor, J.-P. (2018) · Neurology · doi:10.1212/wnl.0000000000006007 · Cited by 103
TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia
Tropea, T. F., Mak, J., Guo, M. H., Xie, S. X., Suh, E., Rick, J., Siderowf, A., Weintraub, D., Grossman, M., Irwin, D., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25486 · Cited by 83
Palliative Care and Parkinson's Disease: Caregiver Perspectives
Boersma, I., Jones, J., Coughlan, C., Carter, J., Bekelman, D., Miyasaki, J., Kutner, J., & Kluger, B. (2017) · Journal of Palliative Medicine · doi:10.1089/jpm.2016.0325 · Cited by 85
Walker, R. W. H., & Walker, Z. (2009) · Movement Disorders · doi:10.1002/mds.22591 · Cited by 86
Henríquez, G., Gomez, A., Guerrero, E., & Narayan, M. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00381 · Cited by 83
Large-Scale Wearable Sensor Deployment in Parkinson’s Patients: The Parkinson@Home Study Protocol
Silva de Lima, A. L., Hahn, T., de Vries, N. M., Cohen, E., Bataille, L., Little, M. A., Baldus, H., Bloem, B. R., & Faber, M. J. (2016) · JMIR Research Protocols · doi:10.2196/resprot.5990 · Cited by 63
Brumm, M. C., Siderowf, A., Simuni, T., Burghardt, E., Choi, S. H., Caspell-Garcia, C., Chahine, L. M., Mollenhauer, B., Foroud, T., Galasko, D., et al. (2023) · Journal of Parkinson’s Disease · doi:10.3233/jpd-223433 · Cited by 70
Dementia with Lewy bodies: Challenges in the diagnosis and management
Chin, K. S., Teodorczuk, A., & Watson, R. (2019) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419835029 · Cited by 63
Xing, Y., Tang, Y., Zhao, L., Wang, Q., Qin, W., Ji, X., Zhang, J., & Jia, J. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.09.028 · Cited by 63
Pharmacologic Treatment of Motor Symptoms Associated with Parkinson Disease
Poewe, W., & Mahlknecht, P. (2020) · Neurologic Clinics · doi:10.1016/j.ncl.2019.12.002 · Cited by 60
Endres, K., & Schäfer, K.-H. (2018) · Journal of Innate Immunity · doi:10.1159/000488629 · Cited by 52
A Systematic Review of the Neurocognitive Effects of Cannabis Use in Older Adults
Scott, E. P., Brennan, E., & Benitez, A. (2019) · Current Addiction Reports · doi:10.1007/s40429-019-00285-9 · Cited by 48
Bidirectional modulation of Alzheimer phenotype by alpha-synuclein in mice and primary neurons
Khan, S. S., LaCroix, M., Boyle, G., Sherman, M. A., Brown, J. L., Amar, F., Aldaco, J., Lee, M. K., Bloom, G. S., & Lesné, S. E. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1886-z · Cited by 41
Caregiver Burden in Parkinson Disease with Dementia Compared to Alzheimer Disease in Korea
Shin, H., Youn, J., Kim, J. S., Lee, J.-Y., & Cho, J. W. (2012) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988712464819 · Cited by 38
Hsieh, M.-H., Meng, W.-Y., Liao, W.-C., Weng, J.-C., Li, H.-H., Su, H.-L., Lin, C.-L., Hung, C.-S., & Ho, Y.-J. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.05.015 · Cited by 35
Bertrand, J.-A., McIntosh, A. R., Postuma, R. B., Kovacevic, N., Latreille, V., Panisset, M., Chouinard, S., & Gagnon, J.-F. (2016) · Brain Connectivity · doi:10.1089/brain.2015.0390 · Cited by 36
The gut–brain axis in early Parkinson’s disease: from prodrome to prevention
Oliver, P. J., Civitelli, L., & Hu, M. T. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13138-5 · Cited by 42
“…anxiety, and hyposmia, although a range of non-motor symptoms continue to manifest even after a clinical diagnosis of PD is made, such as autonomic dysfunction (urinary symptoms and orthostatic hypotension), fatigue, apathy, pain, mild-cognitive impairment, and ultimately dementia [34, 35].”
Parkinson’s-adapted cognitive stimulation therapy: a pilot randomized controlled clinical trial
Leroi, I., Vatter, S., Carter, L.-A., Smith, S. J., Orgeta, V., Poliakoff, E., Silverdale, M. A., Raw, J., Ahearn, D. J., Taylor, C., et al. (2019) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286419852217 · Cited by 34
Snyder, A., Gruber-Baldini, A. L., Rainer von Coelln, F., Savitt, J. M., Reich, S. G., Armstrong, M. J., & Shulman, L. M. (2021) · Journal of Parkinson's Disease · doi:10.3233/jpd-212705 · Cited by 20
Tan, S., Hong, C. T., Chen, J.-H., Chan, L., Chi, W.-C., Yen, C.-F., Liao, H.-F., Liou, T.-H., & Wu, D. (2020) · Brain Sciences · doi:10.3390/brainsci10060337 · Cited by 17
“Patients also experience nonmotor symptoms (NMSs), which adversely affect their cognition, behavior, sleep, and autonomic and sensory function [4].”
BackgroundShould gait speed be included in the clinical evaluation of Parkinson’s disease?
Nocera, J., & Hass, C. (2012) · Advances in Parkinson's Disease · doi:10.4236/apd.2012.11001 · Cited by 8
Metadata
- Authors
- Hely, M. A., Reid, W. G. J., Adena, M. A., Halliday, G. M., & Morris, J. G. L.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2008-04-24
- Volume
- 23
- Issue
- 6
- Pages
- 837-844
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2016109926
- Cited by
- 2,246
- References
- 42
- FWCI
- 40.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- Funders
- National Health and Medical Research Council of Australia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.